Letermovir Noninferior for CMV Prophylaxis in Kidney Recipients

TUESDAY, June 13, 2023 (HealthDay News) -- Letermovir is noninferior to valganciclovir for prevention of cytomegalovirus (CMV) among CMV-seronegative kidney transplant recipients who receive an organ from a CMV-seropositive donor,

Related Keywords

San Diego ,California ,United States ,American ,Ajit Limaye ,Elana Gotkine ,University Of Washington ,American Society Of Transplant Surgeons ,American Transplant Congress ,Journal Of The American Medical Association ,American Society Of Transplantation ,Healthday News ,American Medical ,American Society ,Transplant Surgeons ,